2-47803442-CTA-CTATA

Variant names:

• chr2-47803442-C-CTA
• rs63749821
• NM_000179.3:c.3198_3199dupTA

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1 PM2 PP5_Very_Strong

The NM_000179.3(MSH6):​c.3198_3199dupTA​(p.Ser1067IlefsTer13) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★★). Synonymous variant affecting the same amino acid position (i.e. S1067S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

• Frequency: Genomes: not found (cov: 32)
• Consequence: MSH6 NM_000179.3 frameshift
• Clinical Significance: Pathogenic reviewed by expert panel P:4
• Conservation: PhyloP100: 5.12
• Publications: 3 publications found

Genes affected

MSH6 (HGNC:7329): (mutS homolog 6) This gene encodes a member of the DNA mismatch repair MutS family. In E. coli, the MutS protein helps in the recognition of mismatched nucleotides prior to their repair. A highly conserved region of approximately 150 aa, called the Walker-A adenine nucleotide binding motif, exists in MutS homologs. The encoded protein heterodimerizes with MSH2 to form a mismatch recognition complex that functions as a bidirectional molecular switch that exchanges ADP and ATP as DNA mismatches are bound and dissociated. Mutations in this gene may be associated with hereditary nonpolyposis colon cancer, colorectal cancer, and endometrial cancer. Transcripts variants encoding different isoforms have been described. [provided by RefSeq, Jul 2013]

FBXO11 (HGNC:13590): (F-box protein 11) This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. It can function as an arginine methyltransferase that symmetrically dimethylates arginine residues, and it acts as an adaptor protein to mediate the neddylation of p53, which leads to the suppression of p53 function. This gene is known to be down-regulated in melanocytes from patients with vitiligo, a skin disorder that results in depigmentation. Polymorphisms in this gene are associated with chronic otitis media with effusion and recurrent otitis media (COME/ROM), a hearing loss disorder, and the knockout of the homologous mouse gene results in the deaf mouse mutant Jeff (Jf), a single gene model of otitis media. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2010]

FBXO11 Gene-Disease associations (from GenCC):

• intellectual developmental disorder with dysmorphic facies and behavioral abnormalities

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

ACMG classification

Our verdict: Pathogenic. The variant received 18 ACMG points.

• PVS1: Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
• PM2: Very rare variant in population databases, with high coverage
• PP5: Variant 2-47803442-C-CTA is Pathogenic according to our data. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47803442-C-CTA is described in CliVar as Pathogenic. Clinvar id is 89351.Status of the report is reviewed_by_expert_panel, 3 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
MSH6	NM_000179.3	c.3198_3199dupTA	p.Ser1067IlefsTer13	frameshift_variant	Exon 5 of 10	ENST00000234420.11	NP_000170.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
MSH6	ENST00000234420.11	c.3198_3199dupTA	p.Ser1067IlefsTer13	frameshift_variant	Exon 5 of 10	1	NM_000179.3	ENSP00000234420.5

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 33

GnomAD4 genome Cov.: 32

Alfa AF: 0.00 Hom.: 0

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:4

Revision: reviewed by expert panel

Submissions by phenotype

Lynch syndrome 5 Pathogenic:1

Aug 22, 2023

Myriad Genetics, Inc.

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -

Lynch syndrome Pathogenic:1

Sep 05, 2013

International Society for Gastrointestinal Hereditary Tumours (InSiGHT)

Significance: Pathogenic

Review Status: reviewed by expert panel

Collection Method: research

Coding sequence variation resulting in a stop codon -

Hereditary nonpolyposis colorectal neoplasms Pathogenic:1

Oct 10, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This sequence change creates a premature translational stop signal (p.Ser1067Ilefs*13) in the MSH6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MSH6 are known to be pathogenic (PMID: 18269114, 24362816). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with endometrial cancer (PMID: 12732731). This variant is also known as "Insert TA after 3195". For these reasons, this variant has been classified as Pathogenic. -

Hereditary cancer-predisposing syndrome Pathogenic:1

Jan 09, 2025

Ambry Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The c.3198_3199dupTA pathogenic mutation, located in coding exon 5 of the MSH6 gene, results from a duplication of TA at nucleotide positions 3198 to 3199, causing a translational frameshift with a predicted alternate stop codon (p.S1067Ifs*13). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
PhyloP100		5.1
Mutation Taster		=0/200	disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs63749821; hg19: chr2-48030581;